Oslo, 6 May 2020: Ultimovacs ASA (“Ultimovacs”, ticker ULTIMO), a pharmaceutical company developing novel immunotherapies against cancer, invites to a webcast presentation of its first quarter 2020 results on Thursday 14 May 2020.
The presentation can be followed as a live webcast (access through link https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20200514_4) at 09:00 CET on Thursday 14 May 2020. The webcast presentation will be available on our website, and it will be possible to post questions during the presentation through the webcast.
The report and presentation will be available on the company website from 08:00 CET the same day.
For further information, please see www.ultimovacs.com or contact:
Øyvind Kongstun Arnesen, CEO oeyvind.arnesen@ultimovacs.com, +47 469 33 810
Hans Vassgård Eid, CFO hans.eid@ultimovacs.com, +47 482 48 632